Patent · US Active

Methods for treating multiple sclerosis using antisense oligonucleotides

US8415314B2 · kind B2 · utility

2Cited by
2References
33Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 23, 2009
Grant dateApr 9, 2013
Priority date
Expiry dateJun 23, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/346
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for treating a patient suffering from multiple sclerosis, particularly a relapsing form of multiple sclerosis, comprising periodically administering a pharmaceutical composition comprising a therapeutically effective amount of OLIGONUCLEOTIDE 1 to the patient, thereby treating the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.